Abstract
Systemic inflammation plays an important role in the development of atherosclerosis (AS). The aim of this study was to evaluate the presence of early AS in patients with familial Mediterranean fever (FMF) that is characterized by recurrent inflammatory attacks of serositis. Sixty-one FMF patients (30 Male/31 Female; 31.5 [18–54] years) and 31 healthy controls (16 Male/15 Female; 31 [22–58] years) were studied. All FMF patients were on regular daily colchicine treatment and during attack-free periods. Both the FMF patients and controls with a history of diabetes mellitus (DM), hypertension, and hyperlipidemia were excluded. Body mass index (BMI) was calculated. Serum lipids, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were assessed. Two-hour oral glucose tolerance test was performed to rule out DM and glucose intolerance. To investigate early AS “endothelium-dependent flow-mediated dilatation (FMD%),” “nitroglycerin-induced endothelium-independent peripheral vasodilatation (NTG%),” and intima-media thickness (IMT) of common carotid arteries (CCA) were measured by ultrasonograpy. The median disease duration for FMF patients was 16 (1–45) years. Age, sex, BMI, smoking status, and serum lipids were comparable in patients and controls (p > 0.05). However, ESR and standard CRP were significantly higher in the patients group (p < 0.05). There were no differences in the measurements of right, left, and averaged IMT of CCA between patients and controls ([0.49 vs 0.5], [0.51 vs 0.52] and [0.5 vs 0.51]; p > 0.05, respectively). None of the subjects had carotid artery plaques. FMD% and NTG% were also similar in patients and controls group ([18.2 vs 20.6] and [24.2 vs 22.5]; p > 0.05, respectively). This study suggests that the markers of early AS are not impaired in FMF patients on regular daily colchicine treatment.
Similar content being viewed by others
Abbreviations
- AS:
-
atherosclerosis
- BAD:
-
brachial artery diameter
- BMI:
-
body mass index
- CCA:
-
common carotid artery
- CRP:
-
C-reactive protein
- CV:
-
cardiovascular
- DM:
-
diabetes mellitus
- ESR:
-
erythrocyte sedimentation rate
- FMD:
-
flow-mediated dilatation
- FMF:
-
familial Mediterranean fever
- HDL:
-
high density lipoprotein
- HT:
-
hypertension
- IMT:
-
intima-media thickness
- LDL:
-
low density lipoprotein
- NTG:
-
nitroglycerin
- RA:
-
rheumatoid arthritis
- SLE:
-
systemic lupus erythematosus
- SPSS:
-
Statistical Package of Social Science
- TC:
-
total cholesterol
- TG:
-
triglycerides
References
Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43(2):227–53 (Aug)
Onen F (2006) Familial mediterranean fever. Rheumatol Int 26(6):489–496 (Apr)
Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatol (Oxf) 45:746-750 (Feb 9)
Tunca M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response and evolution of familial Mediterranean fever. Lancet 353(9162):1415 (Apr 24)
Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314(16):1001–1005 (Apr 17)
Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD (2002) Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 1(6):338–347 (Dec)
Manzi S, Wasko MC (2000) Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 59(5):321–325 (May)
Haskard DO (2004) Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol 33(5):281–292
Peters MJ, Van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34(3):585–592 (Dec)
Meyer O (2001) Atherosclerosis and connective tissue diseases. Jt Bone Spine 68(6):564–575 (Dec)
Poredos P (2004) Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis. Vasc Med 9(1):46–54 (Feb)
Raitakari OT, Celermajer DS (2000) Flow-mediated dilatation. Br J Clin Pharmacol 50(5):397–404 (Nov)
Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362(6423):801–809 (Apr 29)
Van Doornum S, McColl G, Jenkins A, Green DJ, Wicks IP (2003) Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 48(1):72–80 (Jan)
Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH (2002) Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 29(2):292–297 (Feb)
Oflaz H, Mercanoglu F, Karaman O, Kamali S, Erer B, Genchellac H et al (2005) Impaired endothelium-dependent flow-mediated dilation in Behçet’s disease: more prominent endothelial dysfunction in patients with vascular involvement. Int J Clin Pract 59(7):777–781 (Jul)
Sari I, Okan T, Akar S, Cece H, Altay C, Secil M et al (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatol (Oxf) 45(3):283–286 (Mar)
Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolsky D et al (2001) Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 3(1):9–12 (Jan)
Akdogan A, Calguneri M, Kalyoncu U, Yavuz B, Karadag O, Aytemir K et al (2005) Endothelium-dependent flow-mediated dilatation is impaired in Familial Mediterranean Fever. Ann Rheum Dis 64(Suppl III):542
Bilginer Y, Basaran C, Ozaltin F, Besbas N, Topaloglu R, Ozen S et al (2006) Long term implications of inflammation in Familial Meditereanean Fever assessed by intima media thickness: a predictor for atherosclerosis?. Ann Rheum Dis 65 (Suppl II):100
Seyahi E, Ugurlu S, Cumali R, Balci H, Yazici H, Ozdogan H (2005) Subclinical atherosclerosis in familial Mediterranean fever. Proceedings of the 4th international congress on systemic autoinflammatory diseases “FMF and Beyond”. Bethesda, MD
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885 (Oct)
(1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20(7):1183–1197 (Jul)
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Bmj 321(7255):199–204 (Jul 22)
Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N et al (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112(21):3337–3347 (Nov 22)
Farzaneh-Far A, Roman MJ (2005) Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Pract 59(7):823–824 (Jul)
Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2399–2406 (Dec 18)
Blann AD (2000) Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?. Blood Coagul Fibrinolysis 11(7):623–630 (Oct)
Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108(24):2957–2963 (Dec 16)
Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?. Arthritis Rheum 46(4):862–873 (Apr)
Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G (1995) Colchicine alters the quantitative and qualitative display of selections on endothelial cells and neutrophils. J Clin Invest 96(2):994–1002 (Aug)
Ben-Chetrit E, Bergmann S, Sood R (2006) Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatol (Oxf) 45(3):274–282 (Mar)
Ozcakar ZB, Yalcinkaya F, Yuksel S, Acar B, Gokmen D, Ekim M (2006) Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol 25(2):149–152 (Mar)
Agewall S (2003) Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor?. Curr Vasc Pharmacol 1(2):107–109 (Jun)
Berghoff M, Kathpal M, Khan F, Skinner M, Falk R, Freeman R (2003) Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis. Annals of neurology 53(6):725–730 (Jun)
Bozkurt AI, Sahinoz S, Ozcirpici B, Ozgur S, Sahinoz T, Acemoglu H et al (2006) Patterns of active and passive smoking, and associated factors, in the South-east Anatolian Project (SEAP) region in Turkey. BMC public health 6:15
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sari, I., Karaoglu, O., Can, G. et al. Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26, 1467–1473 (2007). https://doi.org/10.1007/s10067-006-0529-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0529-2